thioctic acid has been researched along with Cytokine Release Syndrome in 2 studies
Thioctic Acid: An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.
Cytokine Release Syndrome: A severe immune reaction characterized by excessive release of CYTOKINES. Symptoms include DYSPNEA; FEVER; HEADACHE; HYPOTENSION; NAUSEA; RASH; TACHYCARDIA; HYPOXIA; HYPERFERRITINEMIA, and MULTIPLE ORGAN FAILURE. It is associated with viral infections, SEPSIS; AUTOIMMUNE DISEASES and a variety of factors used in IMMUNOTHERAPY.
Excerpt | Relevance | Reference |
---|---|---|
"The "cytokine storm" observed in patients with severe COVID-19 contributes to the destruction of the endothelium, leading to "acute respiratory distress syndrome" (ARDS), multiorgan failure, and death." | 2.72 | Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection. ( Ghibu, S; Rochette, L, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Rochette, L | 1 |
Ghibu, S | 1 |
Uberti, F | 1 |
Ruga, S | 1 |
Farghali, M | 1 |
Galla, R | 1 |
Molinari, C | 1 |
1 review available for thioctic acid and Cytokine Release Syndrome
Article | Year |
---|---|
Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection.
Topics: Angiotensin-Converting Enzyme 2; Animals; Antioxidants; Cardiovascular Diseases; COVID-19; COVID-19 | 2021 |
1 other study available for thioctic acid and Cytokine Release Syndrome
Article | Year |
---|---|
A Combination of α-Lipoic Acid (ALA) and Palmitoylethanolamide (PEA) Blocks Endotoxin-Induced Oxidative Stress and Cytokine Storm: A Possible Intervention for COVID-19.
Topics: COVID-19; Cytokine Release Syndrome; Cytokines; Endotoxins; Humans; Lipopolysaccharides; Oxidative S | 2023 |